Research in Action
En podkast av Oracle Corporation
Kategorier:
31 Episoder
-
AI's Role in Cancer Care Today and Tomorrow
Publisert: 20.8.2024 -
Transforming public health with unstructured data and NLP in FDA's Sentinel Initiative
Publisert: 23.7.2024 -
Empowering Patient-Centered Research Through Technology and Engagement
Publisert: 9.7.2024 -
Advancing clinical research through tech and teamwork
Publisert: 4.6.2024 -
How Innovation is Redefining Health and Life Sciences
Publisert: 22.5.2024 -
Exploring New Frontiers in Pharma: Mindsets, Data, AI, and Oracle
Publisert: 30.4.2024 -
Unlocking Innovation Through Public, Private, and Academic Partnerships
Publisert: 16.4.2024 -
Advancing scientific discovery with patient-led research
Publisert: 19.3.2024 -
Bringing clinical research into everyday patient care
Publisert: 5.3.2024 -
Building patient-friendly access to clinical trials
Publisert: 20.2.2024 -
Data hippies, real-world evidence, and precision medicine
Publisert: 6.2.2024 -
Advancing rare disease research with a patient-centered approach
Publisert: 24.1.2024 -
Automation, innovation, and the future of drug safety
Publisert: 9.1.2024 -
Patient empowerment, digital innovation, and rare diseases
Publisert: 5.10.2023 -
Biotech startup working with Oracle to innovate for pharma
Publisert: 20.9.2023 -
Science, Research, and Reaching the UN SDGs
Publisert: 6.9.2023 -
Talking AI, Computer Vision, Autism, and Small Data Problems
Publisert: 16.8.2023 -
Cloud technology’s impact on epidemiology research and public health
Publisert: 12.7.2023 -
Transforming healthcare research with technology's latest capabilities
Publisert: 28.6.2023 -
The rise of research entrepreneurs and why it matters
Publisert: 14.6.2023
"Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in connecting clinical research with patient care. Hear insightful conversations with scientists, clinicians, and leaders from pharma, biotech, and health.